Qu Wei, Fan Li, Kim Yun-chul, Ishikawa Shizuma, Iguchi-Ariga Sanae M M, Pu Xiao-Ping, Ariga Hiroyoshi
Laboratory of Molecular Biolgy, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
J Pharmacol Sci. 2009 Jun;110(2):191-200. doi: 10.1254/jphs.09045fp. Epub 2009 Jun 5.
DJ-1, a causative gene product of a familial form of Parkinson's disease (PD), PARK7, plays a role in anti-oxidative stress, and loss of its function is thought to result in the onset of PD. Superfluous oxidation of cysteine at amino acid 106 (C106) of DJ-1 renders DJ-1 inactive, and such oxidized DJ-1 was observed in patients with the sporadic form of PD. In this study, we examined the relationship between DJ-1 and compounds extracted from traditional Chinese medicines possessing anti-oxidant activity. Of the 12 compounds tested, 5 were found to specifically bind to the C106 region by using a quartz crystal microbalance. Although 4 compounds prevented rat PC12 and primary neuronal cells from undergoing H2O2-induced cell death, the protective activity of 2 compounds, kaempferol 3-O-beta-rutinoside and 6-hydroxykaempferol 3,6-di-O-beta-D-glucoside, was diminished in cells transfected with siRNA targeting DJ-1, indicating DJ-1-dependent reaction of these compounds. Furthermore, these compounds reduced the level of reactive oxygen species and restored tyrosine hydroxylase activity that had been induced and compromised, respectively, by treatment of cells with H2O2. The results suggest that these compounds are useful lead compounds for PD therapy.
DJ-1是家族性帕金森病(PD)的致病基因产物PARK7,在抗氧化应激中发挥作用,其功能丧失被认为会导致PD的发病。DJ-1第106位氨基酸(C106)处的半胱氨酸过度氧化会使DJ-1失活,并且在散发性PD患者中观察到了这种氧化的DJ-1。在本研究中,我们研究了DJ-1与从具有抗氧化活性的中药中提取的化合物之间的关系。在测试的12种化合物中,通过使用石英晶体微天平发现有5种化合物特异性结合到C106区域。尽管有4种化合物可防止大鼠PC12细胞和原代神经元细胞发生H2O2诱导的细胞死亡,但在用靶向DJ-1的siRNA转染的细胞中,山奈酚3-O-β-芸香糖苷和6-羟基山奈酚3,6-二-O-β-D-葡萄糖苷这2种化合物的保护活性减弱,表明这些化合物的反应依赖于DJ-1。此外,这些化合物降低了活性氧水平,并恢复了分别因用H2O2处理细胞而诱导和受损的酪氨酸羟化酶活性。结果表明,这些化合物是用于PD治疗的有用先导化合物。